Reduction of Sympathetic Hyperactivity by Enalapril in Patients with Chronic Renal Failure

  • Ligtenberg G
  • Blankestijn P
  • Oey P
  • et al.
406Citations
Citations of this article
63Readers
Mendeley users who have this article in their library.

Abstract

Background Inhibition of angiotensin-converting enzyme (ACE) reduces the risk of cardiovascular problems in patients with chronic renal failure. This effect may be due in part to a decrease in sympathetic nervous activity, but no direct evidence of such an action is available. Methods We studied muscle sympathetic-nerve activity in 14 patients with hypertension, chronic renal failure, and increased plasma renin activity before, during, and after administration of the ACE inhibitor enalapril. Ten other patients with similar clinical characteristics were studied before and during treatment with the calcium-channel blocker amlodipine. Normal subjects matched for age and weight were included in both studies. Results At base line, mean (±SD) muscle sympathetic-nerve activity was higher in the group of patients who received enalapril than in the control subjects (35±17 vs. 19±9 bursts per minute, P=0.004). The baroreflex curve, which reflects changes in muscle sympathetic-nerve activity caused by manipulations ...

Cite

CITATION STYLE

APA

Ligtenberg, G., Blankestijn, P. J., Oey, P. L., Klein, I. H. H., Dijkhorst-Oei, L.-T., Boomsma, F., … Koomans, H. A. (1999). Reduction of Sympathetic Hyperactivity by Enalapril in Patients with Chronic Renal Failure. New England Journal of Medicine, 340(17), 1321–1328. https://doi.org/10.1056/nejm199904293401704

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free